SoftWave Tissue Regeneration Technologies, a medical device company specializing in extracorporeal shockwave therapy, will utilize DataBiologics to track outcomes on their device.
DataBiologics will empower a select group of physicians utilizing the SoftWave device to participate in a real-world evidence study on the clinical outcomes of these innovative treatments.
"We are excited to partner with DataBiologics as SoftWave is on the cutting edge of regenerative medicine and we are looking forward to documenting our incredible patient outcomes,” said John Warlick, CEO of SoftWave. "SoftWave is used by leading physicians and DataBiologics’ platform will allow providers to validate the decrease in pain and improved quality of life."
Learn More About Each Company:
SoftWave TRT, LLC (SWTRT) is a medical technology company that is developing advanced solutions specializing in shockwave therapy for better patient healing. Founded in 2004 and headquartered in Kennesaw, GA, SWTRT is committed to the scientific advancement of tissue healing and regeneration and the development of the most effective innovations to improve the quality of lives globally.
SWTRT technology is used worldwide in the healthcare fields of orthopedics, traumatology, wound care, aesthetics and urology.
DataBiologics empowers healthcare providers with an intuitive platform to study the safety and efficacy of novel treatments in orthopedics and beyond. This real-world patient data will empower providers, patients and industry with insights to support more informed treatment decisions and better patient care.
Learn more about DataBiologics: https://www.databiologics.com
Learn more about SoftWave: https://softwavetrt.com